{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:52:23Z","timestamp":1786981943655,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIDA","award":["R01 DA045800"],"award-info":[{"award-number":["R01 DA045800"]}]},{"name":"NIDA","award":["P50 DA046351"],"award-info":[{"award-number":["P50 DA046351"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11606-019-05559-6","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T11:03:44Z","timestamp":1576494224000},"page":"792-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Heterogeneity in Prescription Opioid Pain Reliever Misuse Across Age Groups: 2015\u20132017 National Survey on Drug Use and Health"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-8367","authenticated-orcid":false,"given":"Megan S.","family":"Schuler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"5559_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559\u201374.","journal-title":"Annu Rev Public Health."},{"key":"5559_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M17-0865","volume":"167","author":"B Han","year":"2017","unstructured":"Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017;167:293\u2013301.","journal-title":"Ann Intern Med."},{"key":"5559_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.02.010","volume":"186","author":"S Hulme","year":"2018","unstructured":"Hulme S, Bright D, Nielsen S. The source and diversion of pharmaceutical drugs for non-medical use: a systematic review and meta-analysis. Drug Alcohol Depend. 2018;186:242\u201356.","journal-title":"Drug Alcohol Depend."},{"key":"5559_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.drugalcdep.2019.01.008","volume":"197","author":"KR Elliott","year":"2019","unstructured":"Elliott KR, Jones E. The association between frequency of opioid misuse and opioid use disorder among youth and adults in the United States. Drug Alcohol Depend. 2019;197:73\u201377.","journal-title":"Drug Alcohol Depend."},{"key":"5559_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","volume":"374","author":"WM Compton","year":"2016","unstructured":"Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154\u201363.","journal-title":"N Engl J Med."},{"key":"5559_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jpeds.2015.04.071","volume":"167","author":"M Cerda","year":"2015","unstructured":"Cerda M, Santaella J, Marshall BD, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J Pediatr. 2015;167:605\u201312 e1\u20132.","journal-title":"J Pediatr"},{"key":"5559_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.addbeh.2018.04.017","volume":"86","author":"H Guarino","year":"2018","unstructured":"Guarino H, Mateu-Gelabert P, Teubl J, Goodbody E. Young adults\u2019 opioid use trajectories: from nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose. Addict Behav. 2018;86:118\u201323.","journal-title":"Addict Behav."},{"issue":"19","key":"5559_CR8","first-page":"30018","volume":"S0955\u20133959","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019:S0955\u20133959(19)30018\u20130.","journal-title":"Int J Drug Policy"},{"key":"5559_CR9","first-page":"1","volume":"67","author":"H Hedegaard","year":"2018","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011-2016. Natl Vital Stat Rep. 2018;67:1\u201314.","journal-title":"Natl Vital Stat Rep."},{"key":"5559_CR10","unstructured":"CDC WONDER. Multiple cause of death 1999\u20132017. 2019."},{"key":"5559_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107\u201311.","journal-title":"Int J Drug Policy."},{"key":"5559_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/10826084.2010.538461","volume":"46","author":"JA Ford","year":"2011","unstructured":"Ford JA, Lacerenza C. The relationship between source of diversion and prescription drug misuse, abuse, and dependence. Subst Use Misuse. 2011;46:819\u201327.","journal-title":"Subst Use Misuse."},{"key":"5559_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/02791072.2014.916833","volume":"46","author":"R Daniulaityte","year":"2014","unstructured":"Daniulaityte R, Falck R, Carlson RG. Sources of pharmaceutical opioids for non-medical use among young adults. J Psychoactive Drugs. 2014;46:198\u2013207.","journal-title":"J Psychoactive Drugs."},{"key":"5559_CR14","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1097\/j.pain.0000000000001241","volume":"159","author":"TS Schepis","year":"2018","unstructured":"Schepis TS, McCabe SE, Teter CJ. Sources of opioid medication for misuse in older adults: results from a nationally representative survey. Pain. 2018;159:1543\u201349.","journal-title":"Pain."},{"key":"5559_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/CHI.0b013e3181a8130d","volume":"48","author":"TS Schepis","year":"2009","unstructured":"Schepis TS, Krishnan-Sarin S. Sources of prescriptions for misuse by adolescents: differences in sex, ethnicity, and severity of misuse in a population-based study. J Am Acad Child Adolesc Psychiatry. 2009;48:828\u201336.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"5559_CR16","doi-asserted-by":"crossref","unstructured":"Schepis TS, Wilens TE, McCabe SE. Prescription drug misuse: sources of controlled medications in adolescents. J Am Acad Child Adolesc Psychiatry. 2019;58:670\u201380 e4.","DOI":"10.1016\/j.jaac.2018.09.438"},{"key":"5559_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.drugalcdep.2017.03.024","volume":"177","author":"MC Hu","year":"2017","unstructured":"Hu MC, Griesler P, Wall M, Kandel DB. Age-related patterns in nonmedical prescription opioid use and disorder in the US population at ages 12-34 from 2002 to 2014. Drug Alcohol Depend. 2017;177:237\u201343.","journal-title":"Drug Alcohol Depend."},{"key":"5559_CR18","doi-asserted-by":"publisher","first-page":"17m11958","DOI":"10.4088\/JCP.17m11958","volume":"79","author":"SE McCabe","year":"2018","unstructured":"McCabe SE, Teter CJ, Boyd CJ, Wilens TE, Schepis TS. Sources of prescription medication misuse among young adults in the United States: the role of educational status. J Clin Psychiatry. 2018;79:17m11958.","journal-title":"J Clin Psychiatry"},{"key":"5559_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.drugalcdep.2017.10.013","volume":"182","author":"M Wall","year":"2018","unstructured":"Wall M, Cheslack-Postava K, Hu MC, Feng T, Griesler P, Kandel DB. Nonmedical prescription opioids and pathways of drug involvement in the US: generational differences. Drug Alcohol Depend. 2018;182:103\u201311.","journal-title":"Drug Alcohol Depend."},{"key":"5559_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jgs.15659","volume":"67","author":"AJ Rose","year":"2019","unstructured":"Rose AJ, McBain R, Schuler MS, et al. Effect of age on opioid prescribing, overdose, and mortality in Massachusetts, 2011 to 2015. J Am Geriatr Soc. 2019;67:128\u201332.","journal-title":"J Am Geriatr Soc."},{"key":"5559_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","volume":"49","author":"CM Jones","year":"2015","unstructured":"Jones CM, McAninch JK. Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med. 2015;49:493\u2013501.","journal-title":"Am J Prev Med."},{"key":"5559_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ypmed.2018.04.023","volume":"112","author":"R McBain","year":"2018","unstructured":"McBain R, Rose AJ, LaRochelle MR. The U.S. Opioid epidemic: one disease, diverging tales. Prev Med. 2018;112:176\u201378.","journal-title":"Prev Med."},{"key":"5559_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1176\/appi.ps.201500245","volume":"68","author":"B Saloner","year":"2017","unstructured":"Saloner B, Bachhuber M, Barry CL. Physicians as a source of medications for nonmedical use: comparison of opioid analgesic, stimulant, and sedative use in a national sample. Psychiatr Serv. 2017;68:56\u201362.","journal-title":"Psychiatr Serv."},{"key":"5559_CR24","first-page":"626","volume":"62","author":"ZK \u0160id\u00e1k","year":"1967","unstructured":"\u0160id\u00e1k ZK. Rectangular confidence regions for the means of multivariate normal distributions. Journal of the American Statistical Association. 1967;62:626\u201333.","journal-title":"Journal of the American Statistical Association."},{"key":"5559_CR25","doi-asserted-by":"publisher","first-page":"j4355","DOI":"10.1136\/bmj.j4355","volume":"358","author":"ME Socias","year":"2017","unstructured":"Socias ME, Wood E. Epidemic of deaths from fentanyl overdose. BMJ. 2017;358:j4355.","journal-title":"BMJ."},{"key":"5559_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.amepre.2018.01.040","volume":"54","author":"SM Monnat","year":"2018","unstructured":"Monnat SM. Factors associated with county-level differences in U.S. Drug-related mortality rates. Am J Prev Med. 2018;54:611\u201319.","journal-title":"Am J Prev Med."},{"key":"5559_CR27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2105\/AJPH.2019.305136","volume":"109","author":"SM Monnat","year":"2019","unstructured":"Monnat SM, Peters DJ, Berg MT, Hochstetler A. Using census data to understand county-level differences in overall drug mortality and opioid-related mortality by opioid type. Am J Public Health. 2019;109:1084\u201391.","journal-title":"Am J Public Health."},{"key":"5559_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s11524-017-0177-7","volume":"94","author":"K Stewart","year":"2017","unstructured":"Stewart K, Cao Y, Hsu MH, Artigiani E, Wish E. Geospatial analysis of drug poisoning deaths involving heroin in the USA, 2000-2014. J Urban Health. 2017;94:572\u201386.","journal-title":"J Urban Health."},{"key":"5559_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","volume":"46","author":"GJ Unick","year":"2017","unstructured":"Unick GJ, Ciccarone D. US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. Int J Drug Policy. 2017;46:112\u201319.","journal-title":"Int J Drug Policy."},{"key":"5559_CR30","doi-asserted-by":"publisher","first-page":"igz002","DOI":"10.1093\/geroni\/igz002","volume":"3","author":"MW Carter","year":"2019","unstructured":"Carter MW, Yang BK, Davenport M, Kabel A. Increasing rates of opioid misuse among older adults visiting emergency departments. Innov Aging. 2019;3:igz002.","journal-title":"Innov Aging"},{"key":"5559_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.drugalcdep.2018.10.002","volume":"193","author":"AS Huhn","year":"2018","unstructured":"Huhn AS, Strain EC, Tompkins DA, Dunn KE. A hidden aspect of the US opioid crisis: rise in first-time treatment admissions for older adults with opioid use disorder. Drug Alcohol Depend. 2018;193:142\u201347.","journal-title":"Drug Alcohol Depend."},{"key":"5559_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/01634372.2017.1327469","volume":"60","author":"G Cochran","year":"2017","unstructured":"Cochran G, Rosen D, McCarthy RM, Engel RJ. Risk factors for symptoms of prescription opioid misuse: do older adults differ from younger adult patients? Journal of Gerontological Social Work. 2017;60:443\u201357.","journal-title":"Journal of Gerontological Social Work."},{"key":"5559_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.outlook.2017.10.007","volume":"66","author":"YP Chang","year":"2018","unstructured":"Chang YP. Factors associated with prescription opioid misuse in adults aged 50 or older. Nurs Outlook. 2018;66:112\u201320.","journal-title":"Nurs Outlook."},{"key":"5559_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.drugalcdep.2015.05.010","volume":"153","author":"DS Fink","year":"2015","unstructured":"Fink DS, Hu RR, Cerda M, et al. Patterns of major depression and nonmedical use of prescription opioids in the United States. Drug Alcohol Depend. 2015;153:258\u201364.","journal-title":"Drug Alcohol Depend."},{"key":"5559_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ypmed.2019.02.018","volume":"121","author":"BH Han","year":"2019","unstructured":"Han BH, Sherman SE, Palamar JJ. Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016. Prev Med. 2019;121:94\u201398.","journal-title":"Prev Med."},{"key":"5559_CR36","doi-asserted-by":"publisher","first-page":"j760","DOI":"10.1136\/bmj.j760","volume":"356","author":"EC Sun","year":"2017","unstructured":"Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:j760.","journal-title":"BMJ."},{"key":"5559_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","volume":"51","author":"CS Hwang","year":"2016","unstructured":"Hwang CS, Kang EM, Kornegay CJ, Staffa JA, Jones CM, McAninch JK. Trends in the concomitant prescribing of opioids and benzodiazepines, 2002-2014. Am J Prev Med. 2016;51:151\u201360.","journal-title":"Am J Prev Med."},{"key":"5559_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1257\/pol.20170082","volume":"10","author":"A Alpert","year":"2018","unstructured":"Alpert A, Powell D, Pacula RL. Supply-side drug policy in the presence of substitutes: evidence from the introduction of abuse-deterrent opioids. American Economic Journal-Economic Policy. 2018;10:1\u201335.","journal-title":"American Economic Journal-Economic Policy."},{"key":"5559_CR39","doi-asserted-by":"crossref","unstructured":"Evans WN, Lieber E, Power P. How the reformulation of oxycontin ignited the heroin epidemic. National Bureau of Economic Research. 2018;w24475.","DOI":"10.3386\/w24475"},{"key":"5559_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/08897077.2017.1309938","volume":"38","author":"AJ Gordon","year":"2017","unstructured":"Gordon AJ, Harding JD. From education to practice: addressing opioid misuse through health care provider training: a special issue of substance abuse journal. Subst Abus. 2017;38:119\u201321.","journal-title":"Subst Abus."},{"key":"5559_CR41","doi-asserted-by":"crossref","unstructured":"Oldfield BJ, Tetrault JM, Wilkins KM, Edelman EJ, Capurso NA. Opioid overdose prevention education for medical students: adopting harm reduction into mandatory clerkship curricula. Subst Abus. 2019:1\u20136.","DOI":"10.1080\/08897077.2019.1621241"},{"key":"5559_CR42","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","volume":"172","author":"SE Hadland","year":"2018","unstructured":"Hadland SE, Bagley SM, Rodean J, et al. Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder. JAMA Pediatrics. 2018;172:1029\u201337.","journal-title":"JAMA Pediatrics."},{"key":"5559_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1542\/pir.2017-0153","volume":"39","author":"BL Carney","year":"2018","unstructured":"Carney BL, Hadland SE, Bagley SM. Medication treatment of adolescent opioid use disorder in primary care. Pediatr Rev. 2018;39:43\u201345.","journal-title":"Pediatr Rev."},{"key":"5559_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/ADM.0000000000000348","volume":"11","author":"SM Bagley","year":"2017","unstructured":"Bagley SM, Hadland SE, Carney BL, Saitz R. Addressing stigma in medication treatment of adolescents with opioid use disorder. J Addict Med. 2017;11:415\u201316.","journal-title":"J Addict Med."},{"key":"5559_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2017.10.007","volume":"182","author":"AM Carew","year":"2018","unstructured":"Carew AM, Comiskey C. Treatment for opioid use and outcomes in older adults: a systematic literature review. Drug Alcohol Depend. 2018;182:48\u201357.","journal-title":"Drug Alcohol Depend."},{"key":"5559_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1377\/hlthaff.2018.05232","volume":"38","author":"D Powell","year":"2019","unstructured":"Powell D, Alpert A, Pacula RL. A transitioning epidemic: how the opioid crisis is driving the rise in hepatitis c. Health Aff (Millwood). 2019;38:287\u201394.","journal-title":"Health Aff (Millwood)."},{"key":"5559_CR47","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/aje\/kwz061","volume":"188","author":"H Samples","year":"2019","unstructured":"Samples H, Stuart EA, Olfson M. Opioid use and misuse and suicidal behaviors in a nationally representative sample of US adults. Am J Epidemiol. 2019;188:1245\u201353.","journal-title":"Am J Epidemiol."},{"key":"5559_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"UM Reddy","year":"2017","unstructured":"Reddy UM, Davis JM, Ren Z, Greene MF, Opioid Use in Pregnancy NAS, Childhood Outcomes Workshop Invited S. Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the eunice kennedy shriver national institute of child health and human development, American college of obstetricians and gynecologists, American academy of pediatrics, society for maternal-fetal medicine, centers for disease control and prevention, and the march of dimes foundation. Obstet Gynecol. 2017;130:10\u201328.","journal-title":"Obstet Gynecol"},{"key":"5559_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","volume":"65","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, R C. CDC guideline for prescribing opioids for chronic pain \u2014 United States, 2016. MMWR Recomm Rep. 2016;65:1\u201349.","journal-title":"MMWR Recomm Rep"},{"key":"5559_CR50","unstructured":"U.S. Preventive Services Task Force. Draft evidence review: illicit drug use, including nonmedical use of prescription drugs: screening. 2019."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-05559-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-019-05559-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-05559-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T20:12:15Z","timestamp":1606853535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-019-05559-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["5559"],"URL":"https:\/\/doi.org\/10.1007\/s11606-019-05559-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"30 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of NIDA, the NIH, or the US Government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}